← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-078 | 71449-078-51 | Bupivacaine Hydrochloride | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6018 | 71285-6018-1 | Calcium Gluconate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2012 | 70214-2012-1 | Cefazolin | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:176 | 176 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Brimonidine Tartrate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5005 | 26436-5005-2 | Calcium Gluconate Monohydrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6422 | 72682-6422-1 | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4614 | 72934-4614-9 | Ciclopirox Olamine; Terbinafine Hydrochloride; Fluconazole | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:176 | 176 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-131 | 73702-131-10 | Cefazolin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:177 | 177 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-600 | 81375-600-02 | Semaglutide | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bevacizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-622 | 70092-622-03 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:177 | 177 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Brimonidine Tartrate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0418 | 71285-0418-1 | Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7423 | 72934-7423-6 | Ciclopirox Olamine; Clobetasol Propionate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5632 | 26436-5632-5 | Ciprofloxacin; Dexamethasone; Clotrimazole | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2433 | 72627-2433-3 | Cholecalciferol | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:177 | 177 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-133 | 73702-133-02 | Cefazolin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:178 | 178 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6670 | 71266-6670-1 | Sodium Citrate and Gentamicin Solution | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1557 | 5446-1557-01 | Bevacizumab-Awwb | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-623 | 70092-623-03 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0416 | 71285-0416-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7425 | 72934-7425-6 | Ciclopirox Olamine; Salicylic Acid | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1563 | 72934-1563-2 | Clindamycin Phosphate; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:178 | 178 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:178 | 178 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0422 | 83556-0422-2 | Ceftazidime Anhydrous | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:179 | 179 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-069 | 71449-069-11 | Ketamine Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Hydroquinone; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 62295-3319 | 62295-3319-7 | Brompheniramine Maleate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-05 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0407 | 72196-0407-1 | Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-621 | 70092-621-15 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1004 | 73013-1004-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0422 | 72196-0422-1 | Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4360 | 72934-4360-9 | Ciclopirox Olamine; Terbinafine Hydrochloride; Fluconazole | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1573 | 72934-1573-2 | Clindamycin Phosphate; Niacinamide; Spironolactone; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:179 | 179 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:179 | 179 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2433 | 72627-2433-3 | Cholecalciferol | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:180 | 180 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | E2 12.5mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-880 | 69852-880-10 | Brompheniramine Maleate | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Calcium Gluconate; Calcium Saccharate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-603 | 70092-603-46 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-9410 | 72934-9410-1 | Cantharidin; Podophyllum Resin; Salicylic Acid | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5632 | 26436-5632-5 | Ciprofloxacin; Dexamethasone; Clotrimazole | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:180 | 180 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4572 | 72934-4572-3 | Clindamycin Phosphate; Tretinoin; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Pyridoxine Hydrochloride; Methionine; Thiamine Hydrochloride | 2025-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2026-1:180 | 180 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cholecalciferol | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:181 | 181 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-55 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:181 | 181 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:181 | 181 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71283-1010 | 71283-1010-1 | Bupivacaine | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:181 | 181 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0003 | 81483-0003-0 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:181 | 181 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:181 | 181 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cantharidin | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5330 | 71139-5330-1 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71791-0101 | 71791-0101-1 | Brompheniramine Maleate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-0649 | 26436-0649-3 | Carnitine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1303 | 72934-1303-2 | Clindamycin Phosphate; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2562 | 72934-2562-2 | Clindamycin Phosphate; Tretinoin; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6422 | 72682-6422-1 | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:181 | 181 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-168 | 73198-168-30 | Cholecalciferol | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:182 | 182 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-079 | 71449-079-51 | Ropivacaine Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Biotin | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0004 | 81483-0004-0 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-102 | 71449-102-36 | Cantharidin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-106 | 63037-106-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-881 | 69852-881-10 | Brompheniramine Maleate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2012 | 70214-2012-1 | Cefazolin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1313 | 72934-1313-2 | Clindamycin Phosphate; Niacinamide; Spironolactone; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4617 | 72934-4617-8 | Clobetasol Propionate; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:182 | 182 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7555 | 72934-7555-6 | Ciclopirox Olamine; Clobetasol Propionate | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:182 | 182 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Methionine | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:183 | 183 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2004 | 71266-2004-9 | Glycopyrrolate | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:183 | 183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:183 | 183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brilliant Blue G | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-50 | Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:183 | 183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine Hydrochloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:183 | 183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-131 | 73702-131-10 | Cefazolin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-604 | 70092-604-47 | Cefazolin Sodium | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-107 | 63037-107-05 | Bupivacaine Hydrochloride; Fentanyl Citrate | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-158 | 73177-158-01 | Bumetanide | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2011 | 70214-2011-1 | Cefazolin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2302 | 72934-2302-2 | Clindamycin Phosphate; Tretinoin; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5617 | 72934-5617-8 | Clobetasol Propionate; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:183 | 183 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7557 | 72934-7557-6 | Ciclopirox Olamine; Salicylic Acid | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:183 | 183 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Inositol; Methionine; Methylcobalamin | 2026-1 | source_no_ndc | 1 | 2026-10-13 | |||
compounder:184 | 184 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81375-614 | 81375-614-03 | Liraglutide | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Brolucizumab | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-970 | 69374-970-05 | Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ceftazidime | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6591 | 71300-6591-1 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-158 | 73177-158-03 | Bumetanide | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2013 | 70214-2013-1 | Cefazolin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4312 | 72934-4312-3 | Clindamycin Phosphate; Tretinoin; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:184 | 184 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4614 | 72934-4614-9 | Ciclopirox Olamine; Terbinafine Hydrochloride; Fluconazole | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:184 | 184 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-135 | 73198-135-30 | Choline Chloride; Inositol; Pyridoxine Hydrochloride; Methionine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:185 | 185 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine 2mg added to D5W | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azelaic Acid; Tretinoin | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Moxifloxacin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-6001 | 71286-6001-1 | Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefuroxime Sodium | 2022-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-1:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-23 | Cefazolin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5364 | 72934-5364-3 | Clobetasol Propionate; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:185 | 185 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Pyridoxine Hydrochloride; Choline Chloride; Inositol | 2025-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-2:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5632 | 26436-5632-3 | Ciprofloxacin; Dexamethasone; Clotrimazole | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:185 | 185 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6422 | 72682-6422-1 | Choline Chloride; Methionine; Inositol; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:186 | 186 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-100 | 70092-100-50 | Fentanyl PF 50 mcg/ml 55 ml- 60 ml syr | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Azithromycin Monohydrate | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2433 | 72627-2433-3 | Cholecalciferol | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:186 | 186 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-524 | 65302-524-10 | Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-132 | 73702-132-10 | Cefazolin | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4364 | 72934-4364-5 | Clobetasol Propionate; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2321 | 72627-2321-5 | Cyanocobalamin; Semaglutide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5632 | 26436-5632-5 | Ciprofloxacin; Dexamethasone; Clotrimazole | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:186 | 186 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7555 | 72934-7555-6 | Ciclopirox Olamine; Clobetasol Propionate | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:187 | 187 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0407 | 71285-0407-1 | Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aztreonam | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2011 | 70214-2011-1 | Cefazolin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2440 | 72627-2440-1 | Choline Chloride; Methionine | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-044 | 79926-044-04 | Buprenorphine Hydrochloride | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-525 | 65302-525-10 | Bupivacaine Hydrochloride | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:187 | 187 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cefazolin | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6012 | 26436-6012-1 | Clotrimazole; Ciprofloxacin; Dexamethasone | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2321 | 72627-2321-6 | Cyanocobalamin; Semaglutide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1563 | 72934-1563-2 | Clindamycin Phosphate; Niacinamide | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:187 | 187 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-7557 | 72934-7557-6 | Ciclopirox Olamine; Salicylic Acid | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:188 | 188 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8105 | 70168-8105-1 | Testosterone 80mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aztreonam | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bromfenac Sodium; Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:188 | 188 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-2013 | 70214-2013-1 | Cefazolin | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:188 | 188 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Choline Chloride; Methionine; Cyanocobalamin | 2022-2 | source_no_ndc | 1 | 2026-10-13 |